Compare ENTX & SELF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENTX | SELF |
|---|---|---|
| Founded | 2010 | 1983 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.2M | 58.0M |
| IPO Year | 2015 | 1997 |
| Metric | ENTX | SELF |
|---|---|---|
| Price | $1.69 | $5.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $9.00 | $6.00 |
| AVG Volume (30 Days) | ★ 2.9M | 13.5K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 5.25% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.07 | 0.04 |
| Revenue | $42,000.00 | ★ $12,705,245.00 |
| Revenue This Year | N/A | $3.04 |
| Revenue Next Year | N/A | $3.47 |
| P/E Ratio | ★ $23.71 | $129.25 |
| Revenue Growth | N/A | ★ 1.40 |
| 52 Week Low | $0.91 | $4.73 |
| 52 Week High | $3.22 | $5.63 |
| Indicator | ENTX | SELF |
|---|---|---|
| Relative Strength Index (RSI) | 63.26 | 51.01 |
| Support Level | $1.45 | $4.96 |
| Resistance Level | $1.94 | $5.27 |
| Average True Range (ATR) | 0.28 | 0.11 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 30.87 | 64.29 |
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.